Medicine and Dentistry
Aciclovir
16%
Cytomegalovirus Antibody
33%
Diseases
100%
Follow up
16%
Graft Rejection
33%
Health Care Cost
83%
High Risk Population
16%
Immunoglobulin
16%
Kidney
16%
Kidney Graft
66%
Life
33%
Low Risk Population
16%
Mortality
16%
Outpatient
66%
Patient
100%
Prophylaxis
50%
Vaccine
16%
Nursing and Health Professions
Aciclovir
16%
Cost Effectiveness Analysis
50%
Dialysis
33%
Diseases
100%
Donor
66%
Follow up
16%
Graft Rejection
33%
High Risk Population
16%
Hospitalization
16%
Immunoglobulin
16%
Kidney Graft
66%
Low Risk Population
16%
Mortality
16%
Prophylaxis
50%
Vaccine Efficacy
16%
Immunology and Microbiology
Cytomegalovirus Antibody
33%
Dialysis
33%
High Risk Population
16%
Intravenous Immunoglobulin
16%
Kidney
16%
Life
33%
Low Risk Population
16%
Mortality
16%
Transplant Rejection
33%
Transplantation
66%
Vaccine Efficacy
16%